Allakos Runs Up Into A Near-Term Catalyst

Core Viewpoint - The article discusses the trading strategies around biotech stocks, particularly focusing on events such as trial results and NDA/BLA approvals, while also covering companies regulated by the FDA [1]. Group 1 - The focus is on trading biotech stocks based on significant events that can influence stock prices [1]. - The article emphasizes the importance of understanding FDA regulations in the biotech industry [1]. Group 2 - The analyst has a beneficial long position in ALLK, indicating a personal investment interest in the stock [2]. - The article expresses the analyst's opinions without any compensation from the companies mentioned, ensuring an independent viewpoint [2].